Citius announces results of study that mino-lok eradicates s. aureus biofilm more effectively and expeditiously than components

Cranford, n.j., nov. 30, 2020 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced the completion of a boston analytical study...
CTXR Ratings Summary
CTXR Quant Ranking